Obesity Interventions – Market Insights – Middle East

The Middle East obesity intervention market will grow through 2026, driven by increasing penetration of bariatric procedures and a growing obese population. Additionally, rapid growth in the intragastric balloon segment will help counteract declines in the gastric band segment, contributing to overall market expansion.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for obesity interventions in Egypt, Israel, Kuwait, Saudi Arabia, Turkey, and the UAE across a 10-year period.

Differences in obesity prevalence and penetration of interventions have led to wide variations in market value across the Middle Eastern countries.

Which countries have seen a high penetration of obesity interventions?

Which countries have the strongest potential for future growth? In which countries will emerging products be adopted strongly?

How strongly will the obese population in this region grow through the forecast period?

In several Middle Eastern countries, the internal closure device market will be significantly affected by device reuse.

In which countries is device reuse more prevalent? How will this trend affect unit sales and revenues?

How will this trend change going forward?

Several emerging devices that are about to be launched in the US or European market will likely enter the Middle Eastern market in the coming years.

Which devices are anticipated to enter the Middle Eastern market over the forecast period?

Which existing obesity interventions are going to be impacted due to the emergence of these new devices?

What have physicians said about newer interventions such as the POSE procedure?